biote Corp.

NASDAQ:BTMD

Medical - Care Facilities

Healthcare
$1.23 +0.22%

+$0.01 today

Market cap
$54.25M
Beta
1.66
P/E (TTM)
4.5
EPS (TTM)
$0.51
52W Low $1.27High $4.75

Volume 0.11M

Average 0.25M

BTMD Minority Interest

The portion of consolidated subsidiaries' equity owned by outside shareholders.

biote Corp.NASDAQ: BTMD

Minority Interest · Q1 FY2026 · quarter ended Mar 2026

Minority interest rises 57.8% from a year ago

Minority interest stood at $8.14M at the end of Q1 FY2026, up 57.8% from a year earlier and down 0.1% from the prior quarter.

Context

  • Minority interest amounted to 9.1% of total assets at the end of Q1 FY2026, up 5.0 pp from a year earlier.
  • Minority interest increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether minority interest keeps rising in the next quarterly balance sheet after a +57.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.14M-0.1% QoQ
Last fiscal yearDec 2025
$8.14M+118.4% YoY
Year agoMar 2025
$5.16M+57.8% since
Minority Interest past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+57.8%——
1 year+118.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Minority Interest history

USD · from the balance sheet

Latest · FY2025
8.14M USD
Year-over-year change
+118.4%

Minority Interest vs competitors

How BTMD compares with its peers on the latest reported figures

  • BTMD's Mar 2026 minority interest of $8.14M is the highest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of +57.8% is the highest of 2, against a peer median of +0.0%.
  • Minority interest amounts to 9.1% of total assets for BTMD, versus a peer median of 0.0%.
BTMD Competitors Peer median
Minority Interest for BTMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BTMDbiote Corp.Mar 2026$8.14M +57.8%—9.1%
JYNTThe Joint Corp.Mar 2026$25K +0.0%+0.0%0.0%
VORVor Biopharma Inc.Mar 2026$0 ——0.0%
ANIKAnika Therapeutics, Inc.Mar 2026$0 ——0.0%
ABOSAcumen Pharmaceuticals, Inc.Mar 2026$0 ——0.0%
LUCDLucid Diagnostics Inc.Mar 2026$0 ——0.0%
INOInovio Pharmaceuticals, Inc.Mar 2026$0 ——0.0%
SPROSpero Therapeutics, Inc.Mar 2026$0 ——0.0%
MCRBSeres Therapeutics, Inc.Mar 2026$0 ——0.0%
ACTUActuate Therapeutics IncMar 2026$0 ——0.0%
SCLXScilex Holding CompanyMar 2026-$4.85M ——1.7%
Peer median (excluding BTMD) $0+0.0%+0.0%0.0%

Competitors are the stored peer set for BTMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents26.77M79.23M89M39.34M24.12M
Short-term Investments00000
Net Receivables5.23M6.95M8.17M7.7M7.68M
Inventory9.62M11.18M17.31M14.85M19.06M
Other Current Assets3.94M0308K111K10K
Total Current Assets47.09M101.18M122.34M68.13M54.67M
Property, Plant & Equipment (Net)2.69M3.56M3.1M10.22M13.45M
Goodwill0005.83M5.83M
Intangible Assets4.55M5.07M4.97M9.38M4.27M
Long-term Investments00000
Tax Assets01.84M24.88M28.74M24.79M
Other Non-current Assets00072K4.6M
Total Non-current Assets7.25M10.47M32.95M54.24M52.94M
Total Assets54.33M111.65M155.3M122.37M107.61M
Account Payables4.35M4.11M4.16M5.81M6.83M
Short-term Debt5M6.25M6.25M6.25M6.25M
Tax Payables01.05M17K00
Deferred Revenue1.71M1.97M3M2.96M3.02M
Other Current Liabilities2.21M4.22M6.07M30.32M22.5M
Total Current Liabilities17.31M18.77M22.22M51.51M44.99M
Long-term Debt31.96M112.09M106.63M101.2M100.78M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)802K926K1.32M1.55M1.1M
Other Non-current Liabilities802K36.21M59.99M67.41M8.84M
Total Non-current Liabilities32.89M151.15M169.63M173.06M113.02M
Total Liabilities50.21M169.92M191.84M224.57M158.01M
Common Stock06K6K4K4K
Retained Earnings4.17M(44.46M)(29.39M)(100.3M)(49.55M)
Accumulated OCI(40K)(5K)(12K)(35K)(29K)
Other Stockholders Equity00000
Minority Interest0(13.82M)(7.15M)3.73M8.14M
Total Equity4.13M(58.27M)(36.55M)(102.2M)(50.4M)
Total Debt37.34M120.43M114.87M110.86M109.92M
Net Debt10.57M41.2M25.87M71.52M85.8M

biote Corp.

NASDAQ:BTMD

Intrinsic Alpha fair value

Locked

Current Price

$1.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.